AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

5-Acetyl-6,7,8,4′-tetramethylnortangeretin induces apoptosis in multiple myeloma U266 cells

Dexian Zhia,b,c,1Su Liub,c,1Li Linb,cLiwen Wanga,cJinhan Wanga,cJing MaaSuying WangaHui Zhaoa,dChi-Tang HoeYafei Wanga( )Qiang Liuc ( )
Tianjin Key Laboratory of Food and Biotechnology, School of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China
Key Laboratory of Cancer Prevention and Therapy, Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China
Department of Hematology and Translation Medicine Centre, Hebei Union University Affiliated Hospital, Tangshan 063000, China
Department of Food Science, Rutgers University, New Brunswick, NJ 08901-8502, USA

1 These authors contributed equally to this work.

Peer review under responsibility of Beijing Academy of Food Sciences.

Show Author Information

Abstract

Multiple myeloma (MM) is one of the most common hematological malignancies and to date, it remains an incurable disease. In this study, we evaluated the inhibitory effect of 5-acetyloxy-6,7,8,4′-tetramethoxyflavone (5-ATMF), a compound from aged citrus peel extracts, on the MM U266 cell line. We found that the compound inhibited cell growth and induced cell apoptosis in multiple apoptotic assays. The apoptotic proteins caspase-3, caspase-9, and PARP (poly ADP-ribose polymerase) were cleaved when cells were treated with 5-ATMF. Along with the apoptosis process, the anti-apoptotic protein, Bcl-2 (B-cell lymphoma-2), was significantly downregulated and the pro-apoptotic protein, Bax (Bcl-2 associated X protein), upregulated along with the release of cytochrome C (Cyt c) and the reduction of mitochondrial membrane potential (MMP). Notably, we found that the phosphorylation of Bad (Bcl-2/Bcl-XL-associated death promoter) was decreased but Bad remained unchanged in this process. On adding 5-ATMF to U266 cells, we observed that 5-ATMF repressed the phosphorylation of Akt (PKB Protein Kinase B PKB), thereby increasing the release of Cyt c and inhibiting the phosphorylation of Bad. These effects were enhanced by Ly294002, an inhibitor of Akt. These results suggested that 5-ATMF exerts a pro-apoptotic effect on U266 cells, possibly associated with the mitochondrial apoptotic pathway induced by the PI3K/Akt/Bad pathway.

References

[1]

B. Sung, A.B. Kunnumakkara, G. Sethi, et al., Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model, Mol. Cancer Ther. 8 (4) (2009) 959-970.

[2]

R.R. Malla, S. Gopinath, C.S. Gondi, et al., uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma, J. Neurooncol. 107 (1) (2012) 69-80.

[3]

J. Li, B. Cao, S. Zhou, et al., Cyproheptadine-induced myeloma cell apoptosis is associated with inhibition of the PI3K/AKT signaling, Eur. J. Haematol. 91 (6) (2013) 514-521.

[4]

Y.C. Kang, K.M. Kim, K.S. Lee, et al., Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation, Cell Death Differ. 11 (12) (2004) 1287-1298.

[5]

K.C. Anderson, R.D. Carrasco, Pathogenesis of myeloma, Annu. Rev. Pathol. 6 (2011) 249-274.

[6]

T. Leonardi, J. Vanamala, S.S. Taddeo, et al., Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats, Exp. Biol. Med. 235 (6) (2010) 710-717.

[7]

C.S. Lai, S. Li, C.Y. Chai, et al., Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite 3′,4′-didemethylnobiletin, derived from nobiletin, Carcinogenesis 29 (12) (2008) 2415-2424.

[8]

J. Kim, G.K. Jayaprakasha, R.M. Uckoo, et al., Evaluation of chemopreventive and cytotoxic effect of lemon seed extracts on human breast cancer (MCF-7) cells, Food Chem. Toxicol. 50 (2) (2012) 423-430.

[9]

K.L. Morley, P.J. Ferguson, J. Koropatnick, Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells, Cancer Lett. 251 (1) (2007) 168-178.

[10]

M.E. Bracke, H.T. Depypere, T. Boterberg, et al., Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer, J. Natl. Cancer Inst. 91 (1999) 354-359.

[11]

J. Wang, Y. Duan, D. Zhi, et al., Pro-apoptotic effects of the novel tangeretin derivate 5-acetyl-6,7,8,4′-tetramethylnortangeretin on MCF-7 breast cancer cells, Cell Biochem. Biophys. 70 (2014) 1255-1263.

[12]

M. Yang, J. Huang, H. Pan, et al., Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells, Int. J. Mol. Med. 22 (2008) 489-496.

[13]

L. Scorrano, S.J. Korsmeyer, Mechanisms of cytochrome C release by proapoptotic BCL-2 family members, Biochem. Biophys. Res. Commun. 304 (2003) 437-444.

[14]

M.H. Harris, C.B. Thompson, The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability, Cell Death Differ. 7 (2000) 1182-1191.

[15]

S. Fulda, E. Meyer, C. Friesen, et al., Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis, Oncogene 20 (2001) 1063-1075.

[16]

J.M. Adams, S. Cory, The Bcl-2 apoptotic switch in cancer development and therapy, Oncogene 26 (2007) 1324-1337.

[17]

L. Jiang, M. Luo, D. Liu, et al., BAD overexpression inhibits cell growth and induces apoptosis via mitochondrial-dependent pathway in non-small cell lung cancer, Cancer Cell Int. 13 (2013) 53.

[18]

L. Wang, J. Wang, L. Fang, et al., Anticancer activities of citrus peel polymethoxyflavones related to angiogenesis and others, Biomed. Res. Int. 2014 (2014) 453972, http://dx.doi.org/10.1155/2014/453972 (Epub 28.08.14).

[19]

M.H. Pan, S. Li, C.S. Lai, et al., Inhibition of citrus flavonoids on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumorigenesis in mice, Food Sci. Human Wellness 1 (2012) 65-73.

[20]

A.M. Martelli, M. Nyåkern, G. Tabellini, et al., Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia, Leukemia 20 (2006) 911-928.

[21]

D.W. Seo, Y.R. Cho, W. Kim, et al., Phytochemical linarin enriched in the flower of chrysanthemum indicum inhibits proliferation of A549 human alveolar basal epithelial cells through suppression of the Akt-dependent signaling pathway, J. Med. Food 16 (12) (2013) 1086-1094.

[22]

S. Zhao, M. Konopleva, M. Cabreira-Hansen, et al., Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias, Leukemia 18 (2004) 267-275.

[23]

P. Sommer, R.L. Cowen, A. Berry, et al., Glucocorticoid receptor over-expression promotes human small cell lung cancer apoptosis in vivo and thereby slows tumor growth, Endocr. Relat. Cancer 17 (2010) 203-213.

[24]

C. Stengel, C.W. Cheung, J. Quinn, et al., Optimal induction of myeloma cell death requires dual blockade of phosphoinositide 3-kinase and mTOR signalling and is determined by translocation subtype, Leukemia 26 (2012) 1761-1770.

Food Science and Human Wellness
Pages 197-203
Cite this article:
Zhi D, Liu S, Lin L, et al. 5-Acetyl-6,7,8,4′-tetramethylnortangeretin induces apoptosis in multiple myeloma U266 cells. Food Science and Human Wellness, 2014, 3(3-4): 197-203. https://doi.org/10.1016/j.fshw.2014.12.003

564

Views

6

Downloads

5

Crossref

N/A

Web of Science

5

Scopus

0

CSCD

Altmetrics

Received: 15 December 2014
Accepted: 27 December 2014
Published: 05 January 2015
© 2015 Beijing Academy of Food Sciences.
Return